drugset / Trial / NCT00246155

Study on the Effects of Botulinum Toxin Type A on Back Muscle in Chronic Low Back Pain

NCT00246155 ↗

Phase 3 Completed 35 enrolled Ipsen
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to analyse the changes in back muscle size and strength following use of Dysport®, and to establish whether there is any association between pain reduction and change in strength, in patients suffering from chronic low back pain.

Timeline

Start
2005-01
Primary completion
2005-07-01
Completion
2005-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic — —

Indications

No indication recorded.